Loteprednol Etabonate

Product NDC
85766-193
11-digit product format
857660193
Labeler code
85766
Product ID
85766-193_4deb1de6-520b-8951-e063-6394a90a33dd
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Loteprednol Etabonate
Dosage form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Labeler
Sportpharm LLC
Application
ANDA215933
Marketing category
ANDA
Marketing start
2023-10-24
Substance
LOTEPREDNOL ETABONATE
Active strength
2 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215933-001LOTEPREDNOL ETABONATELOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A215933-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-128072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-126a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-121c564ffb4f44…
2023-12-20 04:57 UTC2023-12A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-129b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-123f0d92c62455…
2023-05-13 08:27 UTC2023-05A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12053a50430f4f…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215933-001LOTEPREDNOL ETABONATE0.2%SUSPENSION/DROPS / OPHTHALMICAB2023-04-12a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A215933-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215933-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215933-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A215933-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215933-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215933-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215933-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215933-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215933-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215933-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215933-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215933-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215933-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215933-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215933-001AB18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A215933-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A215933-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A215933-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A215933-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A215933-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A215933-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A215933-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A215933-001AB1053a50430f4f…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215933-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Loteprednol Etabonate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LOTEPREDNOL ETABONATE2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
YEH1EZ96K6Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
311381Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1677e1a2-c598-4341-ab01-927f32e1b856Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4f474382-f6ee-e00d-5df3-bba50cddfd89Product name520251114
64ba4d79-5363-eefc-3390-ee5d2a50a350Product name320250304
100e83dc-ec8c-9e2e-76d2-5112415ec972Product name320241008
4300453c-d545-46d1-b115-18b12b4ccf79Product name120210525
3f316f1c-2561-47c9-9865-ba2be69e0b3eProduct name120190614
f1ee2aaf-88da-4841-948b-7d3a6af14e35Product name120181206
aa1cd319-ece7-51f7-3a9d-52a64f5f4e81Product name120140508
b5c5cd73-a27b-5e41-bd36-3de9471473cdProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85766-193-05Loteprednol Etabonate5 mL in 1 BOTTLE, DROPPERSUSPENSION/ DROPS51
85766-193-05Loteprednol Etabonate1 in 1 CARTONSUSPENSION/ DROPS11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Loteprednol EtabonateLOTEPREDNOL ETABONATESentiss Pharmaceuticals LLCf210d817-409f-4e69-b8d0-58883c0b43d32026-04-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215933
application number: ANDA215933
Loteprednol EtabonateLOTEPREDNOL ETABONATESportpharm LLC1677e1a2-c598-4341-ab01-927f32e1b8562026-03-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215933
application number: ANDA215933
ndc (product): 85766-193
Loteprednol EtabonateLOTEPREDNOL ETABONATEARMAS PHARMACEUTICALS INC.36c05fa4-6562-4af8-86ac-e79003ee65dd2024-05-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215933
application number: ANDA215933

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311381loteprednol etabonate 0.2 % Ophthalmic SuspensionPSN1677e1a2-c598-4341-ab01-927f32e1b8561
311381loteprednol etabonate 2 MG/ML Ophthalmic SuspensionSCD1677e1a2-c598-4341-ab01-927f32e1b8561
311381loteprednol etabonate 0.2 % Ophthalmic SuspensionSY1677e1a2-c598-4341-ab01-927f32e1b8561

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
85766-193-05857660193051 BOTTLE, DROPPER in 1 CARTON (85766-193-05) / 5 mL in 1 BOTTLE, DROPPER2026-03-26NoNoCurrent